Sight Sciences Inc (SGHT)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$8.09

Buy

$8.50

arrow-down$-0.18 (-2.17%)

Prices updated at 12 Dec 2025, 21:13 EST
| Prices minimum 15 mins delay
|
Prices in USD

Sector
Healthcare
Industry
Medical Devices
Chairman
-
CEO
Mr. Paul Badawi
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
216
Head office
4040 Campbell Avenue
Menlo Park
United States
94025
mobile
+1 877 266-1144
letter
-

Key personnel

Salary
Mr. Gerhard F. Burbach
Director
-
Ms. Alison Bauerlein
Chief Operating Officer
0.45m
Mr. Jim Rodberg
Chief Financial Officer, Principal Accounting Officer and Treasurer
-
Mr. Donald J. Zurbay
Independent Director
0.07m
Mr. Brenton Taylor
Executive Vice President, Operations
-
Mr. Jeremy B. Hayden
Chief Legal Officer
0.42m
Mr. Paul Badawi
Director, President and Chief Executive Officer
0.64m
Dr. David Badawi, M.D.
Chief Technology Officer and Director
-
Mr. Staffan Encrantz
Non-Executive Chairperson of The Board
0.09m
Dr. Tamara R. Fountain, M.D.
Independent Director
0.06m
Ms. Catherine Mazzacco
Independent Director
0.06m
Dr. Manohar K. Raheja
Executive Vice President, Research and Development
-

Top 5 shareholders

No. of shares
KCK Ltd4,374,975
Long Focus Capital Management, LLC3,193,305
BlackRock Inc2,542,283
Bank of America Corporation2,105,964
Vanguard Group Inc1,804,087

Director dealings

Action
06 Dec 2024-
03 Dec 2024-
29 Nov 2024-
21 Nov 2024-
21 Nov 2024-
19 Nov 2024-
12 Nov 2024-
12 Nov 2024-
21 Oct 2024-
18 Oct 2024-
17 Oct 2024-
16 Oct 2024-
02 Oct 2024-
02 Oct 2024-
01 Oct 2024-
01 Oct 2024-
01 Oct 2024-
02 Jul 2024-
02 Jul 2024-
02 Jul 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.